by xplorelab | Sep 16, 2024 | Funding
Dr. Bernard Thébaud was awarded $2.8 million from the Canadian Institutes of Health Research Clinical Trials Fund for a Phase 2 clinical trial using mesenchymal stromal cells (MSCs) to treat bronchopulmonary dysplasia (BPD) in premature babies. Very premature babies...
by xplorelab | Nov 4, 2020 | Funding, Ottawa Hospital Research Institute, Research, The Ottawa Hospital
A gene therapy in development by researchers at The Ottawa Hospital, CHEO and uOttawa in collaboration with the University of Guelph, is showing dramatic results in mice with this disorder, improving their life expectancy from two days to over six months, according to...
by xplorelab | Jul 1, 2020 | Awards, Funding, Research
Xplore Lab and their collaborators at the University of Guelph have received a Canadian Institutes of Health Research project grant and a Collaborative Health Research Project grant to further develop an AAV vector expressing human SPB to test its potential as a...
by xplorelab | Mar 2, 2020 | Awards, Funding, Research
Dr. Bernard Thébaud and colleagues have received a $638,000 grant from the Stem Cell Network with in-kind matching funds from MDTB Cells GmbH to conduct a phase I clinical trial of umbilical cord cell therapy for premature babies. This trial aims to determine if this...
by xplorelab | May 17, 2019 | Awards, Funding, Media, Ottawa Hospital Research Institute, Research
Dr. Bernard Thébaud and colleagues have been awarded $300,000 from the Ontario Institute for Regenerative Medicine (OIRM) to conduct research in preparation for a clinical trial of umbilical cord stem cell therapy for premature babies with BPD; the team hopes to...
by xplorelab | May 10, 2018 | Funding, Research
Dr. Thébaud and his colleagues have been awarded two new grants to continue conducting research on cell therapies for lung disease. The first grant of $99,900 is from the Stem Cell Network and will support the testing of umbilical cord blood cells for treating high...
